Your shopping cart is currently empty

Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 8-10 weeks |
| Description | Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects. |
| In vitro | Sphingolactone-24 (50 µM; 30 min+24 h) inhibits p38 MAPK phosphorylation induced by LPS and counters its anti-apoptotic effects. |
| In vivo | Sphingolactone-24, administered at a dose of 1 mg/kg intraperitoneally at 3 and 9 hours post LPS exposure, mitigates the severity of LPS-induced acute lung injury (ALI) and enhances survival rates in mice subjected to pulmonary damage due to LPS. In this study, the animal model utilized was C3H/HeN breeder mice, which received LPS at 10 mg/kg via intranasal instillation. The treatment not only improved survival but also significantly reduced the severity of ALI. |
| Synonyms | Sph-24 |
| Molecular Weight | 323.43 |
| Formula | C18H29NO4 |
| Cas No. | 881177-99-7 |
| Smiles | [C@H](NC(/C=C/C=C/C)=O)(CO)[C@]1(CC(CCCCCC)C(=O)O1)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.